Goldman Sachs’s Oak Street Health, Inc. OSH Stock Holding History

Goldman Sachs’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-717,003	Closed	-$27.7M	–	6272
2023 Q1	$27.7M	Sell	717,003 -64,800	-8%	-$2.09M	0.01%	1522
2022 Q4	$16.8M	Sell	781,803 -231,411	-23%	-$4.84M	﹤0.01%	2116
2022 Q3	$24.8M	Buy	1,013,214 +158,157	+18%	+$4.18M	0.01%	1676
2022 Q2	$14.1M	Sell	855,057 -793,117	-48%	-$15.4M	﹤0.01%	2194
2022 Q1	$44.3M	Buy	1,648,174 +340,639	+26%	+$7.18M	0.01%	1377
2021 Q4	$43.3M	Sell	1,307,535 -711,515	-35%	-$26.9M	0.01%	1466
2021 Q3	$85.9M	Buy	2,019,050 +1,224,590	+154%	+$65.8M	0.02%	848
2021 Q2	$46.5M	Buy	794,460 +330,066	+71%	+$19.6M	0.01%	1324
2021 Q1	$25.2M	Buy	464,394 +438,870	+1,719%	+$24.4M	0.01%	1746
2020 Q4	$1.56M	Sell	25,524 -268	-1%	-$14.1K	﹤0.01%	3903
2020 Q3	$1.38M	Buy	+25,792	New	+$1.15M	﹤0.01%	3848

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Goldman Sachs's OSH Position: Q2 2023 in Review

Goldman Sachs sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 717,003 shares — an estimated $27.7M sold.

Goldman Sachs first reported a position in OSH in Q3 2020 and held it in 11 quarters. The position peaked at $85.9M in Q3 2021. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Goldman Sachs reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Goldman Sachs sold 717,003 Oak Street Health, Inc. shares in Q2 2023, an estimated $27.7M.
Goldman Sachs first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 11 quarters.
Goldman Sachs's Oak Street Health, Inc. position peaked at $85.9M in Q3 2021.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.